Opinion|Videos|July 12, 2024
ASCO 2024 Highlights: Long-Term Data and the Future of Combination Therapies in Melanoma
Dr Lipson provides insights surrounding combination therapies in melanoma management.
Advertisement
Episodes in this series
Video content above is prompted by the following:
- What is the value of long-term follow-up data in melanoma? How does this impact use of treatment regimens?
- How do you foresee the role of combination therapies evolving in the treatment of melanoma over the next few years?
Advertisement
Related Content
Advertisement
Advertisement
Advertisement
Trending on AJMC
1
Hans Lee, MD, Discusses “Off-the-Shelf” Solution for Rare Blood Disorder With No Approved Therapies
2
FDA Approves Another OTC Naloxone Nasal Spray for Opioid Overdose
3
Walcker Named President of Cardinal’s The Specialty Alliance, With Strengths in GI, Urology
4
United Therapeutics Plans FDA Submission for Inhaled Treprostinil in IPF
5